Tech Company Financing Transactions

Macro Trials Funding Round

Macro Trials closed a $6 million Seed venture capital round on 6/21/2023. Investors included MBX Capital, Healthy Ventures and Inflect Health.

Transaction Overview

Company Name
Announced On
6/21/2023
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Seed
Proceeds Purpose
Macro is focused on high-value therapeutics -- typically biologics such as drugs for curing blindness -- and Altis is focuse d on cancer. Macro is putting the capital to use developing its infrastructure and expanding geographically.

Company Information

Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
955 Carrillo Dr 100
Los Angeles, CA 90048
USA
Phone
Undisclosed
Email Address
Overview
Macro Trials is the precision research clinical platform, driving increased research velocity and an amplified patient experience to unlock value for all stakeholders in the clinical trial ecosystem. Via its digitally powered infrastructure and "hub-and-spoke" distributed model, Macro partners with pharmaceutical companies, CROs, providers, and health systems to conduct trials for high-value therapeutics. The company's turnkey platform empowers physicians to participate in groundbreaking research via workflow-native efficiency tools, clinical research personnel and a network of logistic partners. Macro's clinical trial intelligence platform and proprietary real-world evidence as a service (RWEaaS) product supports life sciences companies in all aspects of therapeutic research, development, and commercialization.
Profile
Macro Trials LinkedIn Company Profile
Social Media
Macro Trials Company Twitter Account
Company News
Macro Trials News
Facebook
Macro Trials on Facebook
YouTube
Macro Trials on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Iana Dimkova
  Iana Dimkova LinkedIn Profile  Iana Dimkova Twitter Account  Iana Dimkova News  Iana Dimkova on Facebook
Co-Founder
Babak Azizzadeh
  Babak Azizzadeh LinkedIn Profile  Babak Azizzadeh Twitter Account  Babak Azizzadeh News  Babak Azizzadeh on Facebook
Co-Founder
Douglas Hamilton
  Douglas Hamilton LinkedIn Profile  Douglas Hamilton Twitter Account  Douglas Hamilton News  Douglas Hamilton on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/21/2023: Augmenta venture capital transaction
Next: 6/21/2023: Squake venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary